Journal
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY
Volume 16, Issue 1, Pages 20-28Publisher
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/1871520615666150518092027
Keywords
Alkylation; apoptosis; bifunctional; checkpoint arrest; DNA repair; fusion molecule; HDAC inhibition
Categories
Ask authors/readers for more resources
Chemotherapy may still be an essential component to treat cancer in combination with new targeted therapies. But chemotherapy needs to get smarter in order to make those combination regimens more effective and also more tolerable, particularly for an aging population. We describe the first time the synthesis and pharmacological testing of a fusion molecule comprising of the alkylator bendamustine and the HDAC-inhibitor vorinostat. The drug was designed to allow for the exploitation of both mechanisms of action simultaneously with the goal to provide a molecule with superior efficacy over the single agents. The pharmacological testing confirms the full functional capacity of both moieties and encouraging pharmacological data raises the hope that the drug may turn out to be a great addition to the armentarium of anticancer agents.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available